Skip to main content

Table 5 Patients studied – site of infection

From: A new approach to treatment of resistant gram-positive infections: potential impact of targeted IV to oral switch on length of stay

Infecting organism Total no. of patients in this category Number of patients suitable for switch to oral therapy (% of patients with this infecting organism) Number of patients suitable for switch to oral therapy and early discharge (% of patients with this infecting organism)
Coagulase negative staph 44 13 (30%) 9 (21%)
Enterococcus 17 5 (29%) 4 (24%)
MRSA 110 63 (57%) 38 (36%)
Other organisms 7 3 (43%) 3 (43%)
Culture negative 33 9 (27%) 8 (24%)
  Total = 211 93 62